Recent research suggests that select athletes with cardiovascular abnormalities may be able to safely participate in competitive sports after shared decision-making with their clinicians about ...

New real-world data suggest that two out of every five patients with transthyretin amyloid cardiomyopathy treated with ...

Shared decision-making between clinicians and athletes of all ages who have cardiovascular abnormalities and want to participate in competitive sports is essential, according to a new joint scientific ...

Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complication due to its invasive nature. Researchers have now found a way to ...

Recent research suggests that select athletes with cardiovascular abnormalities may be able to safely participate in ...

This educational review will oversee LVT pathophysiology, current status of the guidelines-recommended echocardiographic ... perinatal cardiomyopathy and cardiac amyloidosis.3 37–39 Notably, the ...

2-4 The pathophysiology of ATTR-CM involves amyloid deposits accumulating in the myocardium, leading to left ventricular hypertrophy (LVH) and diastolic dysfunction. It is increasingly recognized as ...

Taking place on February 14-16, 2025, in Washington, the American College of Cardiology (ACC) Advancing the Cardiovascular Care of the Oncology Patient conference is an interdisciplinary and ...

AD neuropathology is due to the progressive deposition of extracellular amyloid-beta (Aβ) peptide and intracellular ... In the adaptive phase of HF, angiogenesis induces cardiac hypertrophy to ...

Also, the ability to return to home from hospital was associated with longevity, and so were return to work and quality of life measures within 1 year after cardiac arrest in a separate model ...

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Cardiac amyloidosis has a wide spectrum of clinical manifestations but the ...